Promoters to Study Vascular Smooth Muscle

Area of Science:

• Vascular Biology
• Cellular Plasticity
• Cardiovascular Research

Background:

• Smooth muscle cells (SMCs) are crucial for blood vessel structure, tone, and remodeling.
• SMC plasticity contributes to both physiological processes and cardiovascular diseases like atherosclerosis.
• Mouse models are essential for studying SMC functions and plasticity.

Purpose of the Study:

• To review SMC-targeting Cre-driver lines (Myh11, Tagln, Acta2) for studying SMC plasticity in vivo.
• To highlight technical considerations and limitations of these Cre-driver models.
• To discuss implications for interpreting cardiovascular phenotypes derived from SMC research.

Main Methods:

• Review of existing literature on SMC-targeting Cre-driver lines.
• Analysis of Cre expression patterns in Myh11, Tagln, and Acta2 promoter-driven lines.
• Discussion of fate mapping studies utilizing inducible CreER^T2 systems.

Main Results:

• Cre-driver lines enable in vivo studies of SMC transdifferentiation and phenotypic diversity.
• Limitations include off-target expression in non-SMC types (myofibroblasts, adipocytes, myeloid cells, platelets) and visceral SMCs.
• Tagln/SM22α-Cre expression in the embryonic heart and non-muscular cells requires careful interpretation.

Conclusions:

• SMC-targeting Cre-driver lines are powerful tools for understanding SMC biology and cardiovascular pathologies.
• Awareness of expression limitations is critical for accurate interpretation of experimental results.
• Advancements in Cre-driver lines and fate mapping promise new insights into SMC research.